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Rapid advances in human genomic research are increasing the availability of genomic data for secondary analysis.
Particularly in the case of vulnerable African populations, ethics and informed consent processes need to be
transparent—both to ensure participant protection, as well as to share skills and to evolve best practice for
informed consent from a shared knowledge base. An open dialogue between all stakeholders can facilitate this.
Keywords: Informed consent, Secondary use, Ethics, AfricaEthical re-use of African genomic data
The health genomics revolution is well under way,
thanks to the increased accessibility of rapidly advancing
sequencing technologies [1]. Africa is primed to enter
this arena, especially given significant new research
support from the Human Heredity and Health in Africa
(H3Africa) Initiative [2] funded by the National Institutes
of Health (NIH, USA) and the Wellcome Trust (UK)
[3]. Within Africa, the support from this initiative is
unprecedented in size and scope, currently including
eight consortia/collaborative centers, eight research
projects, four biorepository projects and a continent-wide
bioinformatics network. Genomic data-sharing and
secondary use is the key to accelerating discovery and
many initiatives such as the Global Alliance for Genomics
and Health [4], and the H3Africa Bioinformatics Network
[5] are enabling data-sharing. This must, however, be
realised within a framework of high ethical standards and
truly informed participant consent [6-8].
Consent for secondary use of data and samples is
sensitive within Africa, for various reasons: localised
cultural sensitivities, and the vast cultural and ethnic
diversity across African populations, are not always
appreciated by external researchers [9]; many African
populations are vulnerable to exploitation because of
low education levels, and poor access to health care
may create dependence on study inclusion for access* Correspondence: nicki@sanbi.ac.za
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and researchers are wary of repeating the historical
outflow of samples and data from the continent through
collaborations outside Africa [12,13].
Institutional and governmental ethics review boards
(IRBs) are currently the gate-keepers for re-use of African
genomic data and for validating informed consent
processes. There are many excellent IRBs and ethicists in
Africa, but they are often under-resourced (for example,
see [14] and [15]). They may lack capacity to train
members in evaluating human genomics research, e.g.
issues with genomic data de-identification,—a conceptual
paradigm shift away from existing clinical and genetic data
that do not encapsulate the individual as a whole. There
is, therefore, a strong need in Africa for ethics skills
development [16], sharing of ethics and informed
consent experiences, and building on current practice.
Ensuring robust informed consent processes is crucial for
protection of African research participants—particularly
because once data leaves Africa under secondary use
consent, it moves beyond the jurisdiction of the country
of origin and participant protection becomes reliant on
the host country.
To date, we have found it surprisingly difficult to
access informed consent templates, standard operating
procedures and ‘information for participants’ from
published African genomic studies [13]. Reluctance to share
ethics and informed consent template documentation may
arise from concerns around privacy and legal implications
for both IRBs and researchers. In the absence of such prior
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without being able to learn from previous studies. Through
this continual reinvention of the informed consent process,
we fail to grow our understanding of beneficence and risks
for African research participants or to improve these
processes incrementally with each new study.
Issues around data re-use and informed consent
may raise concerns about secondary use of participant
genomic data. Currently, a statement about ethics approval
and informed consent is usually provided in publications
and is often considered sufficient for secondary use access
to study data obtained through correspondence with the
authors. In some cases, data access committees may review
proposals for secondary use of genomic data (for example,
see [17]), but the original ethics documentation and
informed consent templates are seldom available for
scrutiny by downstream data users to ensure that partici-
pant consent was fairly and ethically obtained for their own
secondary analysis. Similarly, except for some large-scale
projects of human genetic variation [8], such resources are
seldom available for reference by researchers developing
their own best practice for informed consent.
These issues raise questions around transparency
and skills-sharing to develop the best practice for ethics,
informed consent and participant protection particularly
in Africa—although they are pertinent for all health
genomics research.
Firstly, can journals that publish genomic research
involving human subjects encourage more transparency
through submission of ethics-related documentation and
templates when accepting manuscripts for publication?
This might take the form of providing the option to sub-
mit ethics documentation templates (such as informed
consent templates) for some studies or encouragement
to provide such documentation as supplementary data
where authors are willing to do so. Secondly, can public
databases for human genome data facilitate transparency
around ethics and informed consent processes? Full
ethics documentation could be supplied at the time of
data submission and could be provided to researchers
requesting access to the data through appropriate com-
mittees. Thirdly, should the human genomic research
community explore ways (e.g. through centralized
databases) to share templates for informed consent and
patient information in the interests of ethics skills-sharing
and developing best practices for participant protection?
Such resources could assist researchers in developing
appropriate ethics templates for their own studies (but
should not be seen as developing a ‘one-size-fits-all’
approach to informed consent protocols).
Whilst the answers remain unclear, there is a need for
open dialogue between stakeholders about maintaining
and supporting sustainable ethical compliance and integ-
rity when dealing with human genomic data. As long aseconomic and participant vulnerability for African popula-
tions remains, these issues are particularly pertinent when
dealing with data originating from Africa.
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